The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(4-Cyanophenylmethyl)-4-[2-(4-methoxyphenyl)-4-fluorophenyl]-1-piperazinehexanamide ID: ALA3897426
PubChem CID: 134134456
Max Phase: Preclinical
Molecular Formula: C31H35FN4O2
Molecular Weight: 514.65
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(-c2cc(F)ccc2N2CCN(CCCCCC(=O)NCc3ccc(C#N)cc3)CC2)cc1
Standard InChI: InChI=1S/C31H35FN4O2/c1-38-28-13-10-26(11-14-28)29-21-27(32)12-15-30(29)36-19-17-35(18-20-36)16-4-2-3-5-31(37)34-23-25-8-6-24(22-33)7-9-25/h6-15,21H,2-5,16-20,23H2,1H3,(H,34,37)
Standard InChI Key: PYMZBBSVTWGBTF-UHFFFAOYSA-N
Molfile:
RDKit 2D
38 41 0 0 0 0 0 0 0 0999 V2000
5.4025 -11.9442 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.1102 -11.5356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8180 -11.9442 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1102 -10.7184 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.5257 -11.5356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2334 -11.9442 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9411 -11.5356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6488 -11.9442 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3565 -11.5356 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.0594 -11.9453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7650 -11.5402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7693 -10.7227 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.0617 -10.3119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3499 -10.7187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6948 -11.5356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9871 -11.9442 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4744 -10.3182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1808 -10.7312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8896 -10.3259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8931 -9.5079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1820 -9.0967 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4761 -9.5043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2800 -11.5325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5728 -11.9404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5723 -12.7585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2850 -13.1669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9893 -12.7566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7724 -9.0978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7746 -8.2795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0681 -7.8702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3590 -8.2781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3608 -9.0996 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0678 -9.5051 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8660 -13.1703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1588 -13.5798 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.6018 -9.1010 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
9.6512 -7.8697 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.6509 -7.0526 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
2 4 2 0
3 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
9 14 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
1 15 1 0
15 16 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
12 17 1 0
16 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 16 1 0
28 29 2 0
29 30 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 28 1 0
22 28 1 0
34 35 3 0
25 34 1 0
20 36 1 0
31 37 1 0
37 38 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 514.65Molecular Weight (Monoisotopic): 514.2744AlogP: 5.37#Rotatable Bonds: 11Polar Surface Area: 68.60Molecular Species: BASEHBA: 5HBD: 1#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 8.59CX LogP: 5.45CX LogD: 4.24Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.35Np Likeness Score: -1.35
References 1. Lacivita E, Podlewska S, Speranza L, Niso M, Satała G, Perrone R, Perrone-Capano C, Bojarski AJ, Leopoldo M.. (2016) Structural modifications of the serotonin 5-HT7 receptor agonist N-(4-cyanophenylmethyl)-4-(2-biphenyl)-1-piperazinehexanamide (LP-211) to improve in vitro microsomal stability: A case study., 120 [PMID:27318552 ] [10.1016/j.ejmech.2016.05.005 ]